RPRXRoyalty Pharma plcFeb 11, 2026Q4 2025
Read transcript →Royalty Pharma plc (RPRX) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$49.89
+0.77%
Mkt Cap $21.20B
RPRXRoyalty Pharma plcFeb 11, 2026RPRXRoyalty Pharma plcNov 5, 2025Q3 2025
Read transcript →RPRXRoyalty Pharma plcAug 6, 2025Q2 2025
Read transcript →RPRXRoyalty Pharma plcMay 8, 2025Q1 2025
Read transcript →RPRXRoyalty Pharma plcFeb 11, 2025Q4 2024
Read transcript →RPRXRoyalty Pharma plcNov 6, 2024Q3 2024
Read transcript →RPRXRoyalty Pharma plcAug 8, 2024Q2 2024
Read transcript →RPRXRoyalty Pharma plcMay 9, 2024Q1 2024
Read transcript →RPRXRoyalty Pharma plcFeb 15, 2024Q4 2023
Read transcript →RPRXRoyalty Pharma plcNov 8, 2023Q3 2023
Read transcript →RPRXRoyalty Pharma plcAug 8, 2023Q2 2023
Read transcript →RPRXRoyalty Pharma plcMay 9, 2023Q1 2023
Read transcript →RPRXRoyalty Pharma plcFeb 15, 2023Q4 2022
Read transcript →RPRXRoyalty Pharma plcNov 8, 2022Q3 2022
Read transcript →RPRXRoyalty Pharma plcAug 4, 2022Q2 2022
Read transcript →RPRXRoyalty Pharma plcMay 5, 2022Q1 2022
Read transcript →RPRXRoyalty Pharma plcFeb 15, 2022Q4 2021
Read transcript →RPRXRoyalty Pharma plcNov 10, 2021Q3 2021
Read transcript →RPRXRoyalty Pharma plcAug 11, 2021Q2 2021
Read transcript →RPRXRoyalty Pharma plcMay 11, 2021Q1 2021
Read transcript →RPRXRoyalty Pharma plcFeb 17, 2021Q4 2020
Read transcript →RPRXRoyalty Pharma plcNov 11, 2020Q3 2020
Read transcript →RPRXRoyalty Pharma plcAug 12, 2020Q2 2020
Read transcript →